Search filters

Filters
Clear All

Phase

  • 5
  • 3
  • 4
  • 2
  • 1
  • 6
  • 24
  • 15
  • 24

Found 24 Multiple Sclerosis trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years or below
All genders
Phase 1
This is a Phase 1/2, open-label, multicenter dose-escalation and dose-expansion trial evaluating the safety and tolerability of fimepinostat administered orally to patients with R/R lymphoma.
99 years or below
All genders
Phase 2
Subjects with Stage III resectable melanoma will receive adjuvant therapy, nivolumab or ipilimumab plus nivolumab, based on whether a pathologic complete response (CR) or near CR (less than 10% viable tumor cells) is achieved with one dose of nivolumab in the neoadjuvant setting followed by surgery.
 NEUROIMMUNOLOGY PATIENT RESPONSE TO COVID-19 OUTBREAK
18 years - 99 years
Accepts healthy volunteer
All genders
The purpose of this research study is to understand how our patients with Multiple Sclerosis (MS) and other neuroimmune disorders are being affected by the COVID-19 outbreak. We want to understand how susceptible our patients are to COVID-19. We also want to evaluate the longer-term social and psychological consequences of …
18 years - 99 years
All genders
Observational
Adult patients with Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases will undergo a blood draw and collection of clinical information prior to receipt of COVID-19 vaccination. Subjects will undergo a repeat blood draw and collection of clinical information at 4-10 weeks, 6 months …
21 - 24 of 24